COPPIN BIOLOGICAL SOLUTIONS financials
A multi-period view of the public annual-account figures reported for COPPIN BIOLOGICAL SOLUTIONS, with comparable measures and links to available source documents.
Company overviewRegistry number
0801563854
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for COPPIN BIOLOGICAL SOLUTIONS
2025 versus 2024
- Operating line
- €19,738
- EBITDA
- €18,702
- Total assets
- €80,045
- Equity
- €33,237
-31.2%
-31.8%
+1.6%
+61.9%
EBITDA margin +94.8% · Equity ratio +41.5%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.